Cargando…
Development and validation of a population-based prediction scale for osteoporotic fracture in the region of Valencia, Spain: the ESOSVAL-R study
BACKGROUND: Today, while there are effective drugs that reduce the risk of osteoporotic fracture, yet there are no broadly accepted criteria that can be used to estimate risks and decide who should receive treatment. One of the actual priorities of clinical research is to develop a set of simple and...
Autores principales: | Sanfélix-Genovés, José, Peiró, Salvador, Sanfélix-Gimeno, Gabriel, Giner, Vicente, Gil, Vicente, Pascual, Manuel, Fluixá, Carlos, Fuertes, Antonio, Hurtado, Isabel, Ferreros, Inmaculada |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848634/ https://www.ncbi.nlm.nih.gov/pubmed/20334639 http://dx.doi.org/10.1186/1471-2458-10-153 |
Ejemplares similares
-
Adherence to and appropriateness of anti-osteoporotic treatments in patients aged 50 and over in the Valencia Region (Spain). The ESOSVAL-AD Study
por: Sanfélix-Gimeno, Gabriel, et al.
Publicado: (2011) -
Impact of a multifaceted intervention to improve the clinical management of osteoporosis. The ESOSVAL-F study
por: Sanfélix-Genovés, José, et al.
Publicado: (2010) -
Impact of osteoporosis and vertebral fractures on quality-of-life. a population-based study in Valencia, Spain (The FRAVO Study)
por: Sanfélix-Genovés, José, et al.
Publicado: (2011) -
Impact of Drug Safety Warnings and Cost-Sharing Policies on Osteoporosis Drug Utilization in Spain: A Major Reduction But With the Persistence of Over and Underuse. Data From the ESOSVAL Cohort From 2009 to 2015
por: Hurtado-Navarro, Isabel, et al.
Publicado: (2019) -
Trends and Geographical Variability in Osteoporosis Treatment After Hip Fracture: A Multilevel Analysis of 30,965 Patients in the Region of Valencia, Spain
por: Hurtado, Isabel, et al.
Publicado: (2020)